Worked up

While aggressive work-up of ipsilateral axillary adenopathy is not typically recommended after COVID-19 mRNA vaccination, even in the setting of a history of cancer, this case presentation would like to remind you that this might not be the case in the setting of a new diagnosis of any breast malignancy, including DCIS.